Medivir presents data that strengthens the fostrox/Lenvima combination in primary liver cancer at EASL Liver Cancer Summit ...Middle East

STOCKHOLM, Feb. 22, 2024 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that clinical pharmacokinetic (PK) data on dose linearity and systemic...

Hence then, the article about medivir presents data that strengthens the fostrox lenvima combination in primary liver cancer at easl liver cancer summit was published today ( Thursday 22/02/2024 - 12:00 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Medivir presents data that strengthens the fostrox/Lenvima combination in primary liver cancer at EASL Liver Cancer Summit )

Also on site :

• Large plume of smoke visible from I-290 billows from west suburban building fire
• Legendary Rock Band's Latest Single Is 'Quite Cinematic', Says Lead Singer: Exclusive
• Taylor Frankie Paul Shares Vacation Pics of Kids Amid Custody Drama